Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture ...

Libmeldy is approved by the European Commission (EC) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). For more information, please see the Summary of Product Characteristics ...

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for mRESVIA, indicated for active immunization for the ...

The agreement with SNS follows similar arrangements made with reimbursement authorities in the United Kingdom (UK), Ireland, Germany, Italy, Sweden, Iceland, Finland, Norway, Belgium and The ...

In addition, these potent nucleases are easily packaged into an AAV delivery vector due to their small size. “The compelling preclinical results being presented along with recent favorable feedback ...

MeiraGTx Holdings plc announced promising results from a first-in-human study published in The Lancet, involving a gene therapy treatment for children with AIPL1-associated retinal dystrophy ...

Furthermore, the MHRA has become the first regulator globally ... CRISPR-Cas9, and viral vector engineering strategies, have significantly contributed to rapid growth in CGTs.

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for nemolizumab to treat moderate-to-severe prurigo nodularis in adults and moderate-to-severe ...

The therapy uses an adeno-associated virus vector to carry the gene ... Forge Biologics stated that the Medicines and Healthcare Products Regulatory Agency (MHRA), the UK’s healthcare regulatory body, ...